Additional file 1: of Serum miR-22 as potential non-invasive predictor of poor clinical outcome in newly diagnosed, uniformly treated patients with diffuse large B-cell lymphoma: an explorative pilot study
Fig. S1. Kaplan-Meier Overall Survival curves. Correlation between the indicated miRNAs and the Overall Survival of 47 DLBCL patients from TCGA data analysis. (PDF 204Â kb